PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34464920-0	2022	Multi-Spectroscopic, thermodynamic and molecular dynamic simulation studies for investigation of interaction of dapagliflozin with bovine serum albumin.	dapagliflozin	112-125	albumin	Homo sapiens	138-151	
34464920-3	2022	In this study, the interaction of DAPA with bovine serum albumin (BSA) was investigated for the first time using various fluorescence spectroscopic techniques, UV-absorption spectroscopy, molecular docking, and molecular dynamic (MD) simulation.	dapagliflozin	34-38	albumin	Homo sapiens	51-64	
34258337-3	2021	Data on dapagliflozin"s effects (vs. placebo) on hemoglobin (Hb), hematocrit, serum albumin, serum total protein concentrations, urine albumin/creatinine ratio, eGFR, heart rate, blood pressure, body weight, and safety in patients with type 2 diabetes with and without anemia were pooled and analyzed.	dapagliflozin	8-21	albumin	Homo sapiens	78-91	
34619106-0	2021	Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial.	dapagliflozin	10-23	albumin	Homo sapiens	35-42	
32948397-5	2020	Dapagliflozin"s effects (vs. placebo) on hemoglobin, serum albumin, estimated glomerular filtration rate (eGFR), systolic blood pressure, body weight, and safety in patients with and without anemia were evaluated.	dapagliflozin	0-13	albumin	Homo sapiens	53-66	
32948397-8	2020	Serum albumin increased in dapagliflozin-treated patients at week 4 and remained stable thereafter.	dapagliflozin	27-40	albumin	Homo sapiens	0-13